Trial Profile
Efficacy, Safety, Tolerability, and Pharmacokinetics of TrIP Administered to Subjects With Chronic Obstructive Pulmonary Disease.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Aug 2011
Price :
$35
*
At a glance
- Drugs Trospium chloride (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Adverse reactions; Therapeutic Use
- 18 May 2010 Results have been presented at the 106th International Conference of the American Thoracic Society.
- 08 Aug 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 19 Feb 2009 Top-line results from the full study are expected in the second half of 2009 according to an Alkermes media release.